Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Total 13F shares
-
16,608,544
-
Share change
-
+133,442
-
Total reported value
-
$923,504,856
-
Put/Call ratio
-
126%
-
Price per share
-
$55.73
-
Number of holders
-
144
-
Value change
-
+$5,953,697
-
Number of buys
-
72
-
Number of sells
-
58
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q1 2022
As of 31 Mar 2022,
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) was held by
144 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,608,544 shares.
The largest 10 holders included
ROYAL BANK OF CANADA, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GOLDMAN SACHS GROUP INC, DIMENSIONAL FUND ADVISORS LP, MILLENNIUM MANAGEMENT LLC, JPMORGAN CHASE & CO, and MORGAN STANLEY.
This page lists
144
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.